Articles

State insurance chief Cutter dies

Indiana Insurance Commissioner Carol Cutter passed away Sept. 6 in Indianapolis after a months-long struggle with illness. She was 67. Cutter had been on leave from the department since January.

Read More

Community moves to integrate doctors

Health Care watch videoCommunity Health now has about 550 physicians, either on its payroll or committed through integration contracts, who have some of their pay hinge on measures of quality and communication. CEO Bryan Mills says the hospital system is looking to add even more.

Read More

On-site health care clinics moving beyond traditional settings

Health clinics based in employers’ offices are showing signs of breaking out of their niche among blue collar and government employers—factories, warehouses and school corporations—and could pop up in Class A office buildings filled with white collar workers.

Read More

Clarian expanding neurosurgery unit, aiming for national draw

Methodist Hospital is spending $27 million to renovate its neurosurgery suites as the centerpiece of a big expansion its owner, Clarian Health, hopes will create nearly 1,200 jobs over the next decade and vault Methodist into the top 10 neurosurgery sites in the nation.

Read More

Lilly investing up to $150M in VC funds

The three venture funds, which will focus on drug development, may be worth a total of $750 million, up to $250 million each, and Lilly will contribute as much as 20 percent of the money.

Read More

Indianapolis software firm RealMed acquired

Health care software firm RealMed Corp. will keep its base of operations in Indianapolis after being acquired by health information exchange provider Availity LLC of Jacksonville, Fla. Terms of the deal announced Wednesday were not disclosed.

Read More

Local economic espionage case full of intrigue

The government's allegations read like a spy novel: Dr. Ke-xue "John" Huang lands a job at Indianapolis-based Dow AgroSciences and over five years works himself into a position of trust, with access to trade secrets and processes the company has invested $300 million to develop.

Read More

After health reform, Lilly looking for more

The health reform debate may have ended in Congress, but Eli Lilly and Co. remains active, sponsoring a talk about the positives of the
bill—and calling for further government efforts to help pharmaceutical research and development.

Read More